Stratpharma AG appoints Jeff Wellman as Chief Commercial Officer for North America and Board Member

Stratpharma AG appoints Jeff Wellman as Chief Commercial Officer for North America and Board Member

San Diego, California Oct 20, 2023 (The content of this article comes exclusively from the website

Stratpharma AG, a Swiss-based global leader specializing in innovative topical medical devices for enhancing Oncology Supportive Care, Dermatology, Plastic Surgery, Wound Care and Women’s Health, today announced the appointment of Jeff Wellman as the Chief Commercial Officer for North America, effective from October 1. 2023. Mr. Wellman will be based at the San Diego headquarters of the USA Subsidiary, Stratpharma Inc. Stratpharma’s global headquarters is situated in Basel, Switzerland. In a significant development, Mr. Wellman has also been appointed to serve on the Company’s Board of Directors.


Darren Kerr, CEO of Stratpharma AG, stated, “We are very pleased to welcome an accomplished leader in life sciences like Jeff Wellman. With over 18 years of experience in leadership roles and executing growth-oriented strategies in this market, Jeff’s wealth of knowledge will be pivotal in steering Stratpharma’s commercial efforts in North America. Jeff’s extensive healthcare background and business development skills will help guide Stratpharma to expand and grow our sales and market presence. With Jeff leading our teams in North America, Stratpharma is poised to deliver on our growth strategy in the world’s largest healthcare and pharmaceutical markets.”


Prior to joining Stratpharma, Mr. Wellman held several leadership positions within the healthcare industry, including serving as the Chief Executive Officer at Golden State Biotech and holding Director positions at MiMedx, Organogenesis, MTF Biologics (ConMed), and ACell Inc. (recently acquired by Integra Life Sciences). Mr. Wellman has also served as an external consultant for various M&A consulting firms in the Life Sciences sector.


Mr. Wellman commented on Stratpharma’s prospects in North America, stating, “Stratpharma is poised for rapid growth in North America. We have best in class products that offer real solutions to patients and providers. Our product portfolio offers a platform of value-based care that can create sustainability in the new world of health-economic based patient care. StrataXRT® and StrataGRT® are two innovative and effective products that should absolutely be known throughout the healthcare systems in North America.”


Mr. Wellman holds a Bachelor of Science degree from BYU-Hawaii University, where he played on the school’s collegiate Men’s Water Polo Team.  He has also completed postgraduate studies at Western Governors University and previously served a mission for the LDS Church in Buenos Aires, Argentina.


About Stratpharma AG

Stratpharma AG is a Swiss company based in Basel, specializing in innovative film-forming wound dressings to improve medical and aesthetic outcomes in post-procedure care for Aesthetic Dermatology, Plastic Surgery, Wound Care, Women’s Health, and Oncology Supportive Care. Stratpharma Inc. USA, the U.S. subsidiary of Stratpharma AG, is headquartered in San Diego, California. Stratpharma Inc. USA is responsible for product distribution, customer service and education for healthcare professionals and patients in the U.S. Stratpharma products are available on the Veterans Affairs Federal Supply Schedule (FSS) Contract.

Stratpharma products are registered in over 80 countries and are sold in more than 60 countries worldwide. For more information, visit or call Stratpharma Inc. USA at 619.930.5788.

Jeffrey Wellman

Jeffrey Wellman